Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-008925

Options or other derivatives

  • COO and Secretary acquired 165,143 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schuth Alexander O. COO and Secretary 2020-02-10 Grant or award · Restricted Stock Units +29,143 29,143 D
Schuth Alexander O. COO and Secretary 2020-02-10 Grant or award · Stock Option (right to buy) +136,000 136,000 D
Loading xslF345X03/doc4.xml…